Company founded as wholly-owned subsidiary of Windlas Biotech Limited at Dehradun, Uttarakhand, India
Plant commissioned and licensed to manufacture tablets, capsules and dry powder sachets of general category
Joint Venture partnership with the Medicine Company (NASDAQ – MDCO) for joint India operations
Tano Capital invests in Windlas Biotech Limited
Inspected and approved by health regulatory authorities -
  • USFDA : June 2014, Feb 2016 (Zero 483s)
  • Ukraine : 2012, 2014
  • Kenya: 2013
  • Ivory Coast: 2012
Present - Shipping products for India, Myanmar, Ukraine, Vietnam